| INTRODUCTION
Gulf War Illness (GWI) is a chronic, multisymptom disorder that afflicts 25% to 32% of the nearly 700 000 US veterans who served in the 1990-1991 Gulf War. 1 Veterans with GWI struggle with unabated central nervous system (CNS) deficits including chronic headaches, memory and concentration problems, sleep difficulty, fatigue and mood alterations. [2] [3] [4] Epidemiological and intelligence data indicate that at least 100 000 GW veterans were probably exposed to the organophosphate (OP) nerve agents sarin and cyclosarin, which were released as fallout from demolitions of the ammunition depot at Khamisiyah, Iraq in March 1991. [5] [6] [7] While acute symptoms of OP toxicity have been characterized, only recently have the neurological consequences of exposure to low levels of OPs been studied. 8, 9 Understanding the impact on the CNS of low level OP exposure is important because OP pesticides represent the largest group of insecticides, and their use is widespread around the world, with >5 billion pounds of pesticides applied to crops, homes, schools, parks and forests. 10 In addition, the threat of OP nerve agent use in terrorism and war remains a concern. Growing evidence indicates a link between OP pesticide exposure and the development of Parkinson's and Alzheimer's diseases and amyotrophic lateral sclerosis, [11] [12] [13] [14] [15] necessitating a deeper investigation into the underlying mechanisms.
OP nerve agents are known to cause acute life-threatening acetylcholinesterase inhibition. Current thinking is that GWI is not due to acetylcholinesterase inhibition but rather due to subthreshold effects of OPs that produce a nonself-correcting state of neurodegeneration. Neuroinflammation, axonal transport deficits, microtubule impairments and dopaminergic changes have all been observed in † These authors are co-first authors.
animal (rodent) and cell culture models of GWI at OP levels below those needed to inhibit acetylcholinesterase. [16] [17] [18] Additional animal studies have shown that the effects of OP exposures are exacerbated when coupled with physical restraint or chemically induced stressors designed to mimic the physical stress of the battlefield. 19 We are interested in microtubule deficits that occur in the nervous system of veterans suffering from GWI, with the goal of developing microtubule-based therapies. OPs can affect a variety of proteins and pathways in cells, for example, by covalently binding to tyrosine and lysine residues. The impacts on microtubules and microtubule-related proteins are likely to be many, including effects on molecular motor proteins and microtubule stability and dynamics, as well as the binding to microtubules of microtubule-associated proteins such as tau. [20] [21] [22] [23] [24] In light of the complexity, the question becomes whether particular microtubule-related deficits can be identified that when corrected result in marked improvement of GWI symptoms.
Here, we pretreated cultured neurons with the stress hormone corticosterone (CORT) in the case of rat neurons, and cortisol in the case of human-derived neurons, and then exposed them to diisopropyl fluorophosphate (DFP), an OP compound used by researchers as a sarin-surrogate. 25 We then assessed various microtubule-related parameters such as microtubule dynamics and mitochondrial transport, using live-cell imaging, to ascertain potential deficits. We included in our studies analyses of dopamine release, which is a complex process that involves not only microtubules but many other factors as well. 26 Upon ascertaining that the toxin regimens resulted in diminished microtubule acetylation, we sought to determine whether a drug that increases microtubule acetylation could restore to normal observed deficits in microtubule dynamics and mitochondrial transport, as well as dopamine release. Improvement in dopamine release was taken as an indicator that this approach has the potential to effectively treat complex symptoms of GWI. With the rat neurons, as described in Figure 1A , the ratio was When treated with 10 μM tubacin, mitochondrial transport events were recovered ( Figure 3D ).
| Dopamine release is altered after DFP exposure in a manner exacerbated by CORT pretreatment
Dopamine and neurotransmission alterations have been reported after exposure to GW toxins, 1,4 which we hypothesize in part are due to changes in microtubules, which serve as tracks for synaptic vesicle , which is specific to neurons and is significantly upregulated in mature neurons, is colored red. Tbr1, a transcription factor which serves as a marker for forebrain cortical glutamatergic neurons, is colored green, and 4', 6-Diamidino-2 Phenylindole, Dihydrochloride (DAPI), which stains nuclei, is blue. Scale bar represents 50 μm. C, Coimmunostaining of acetylatedtubulin (green; Sigma Cat. #T6793) and βIII-tubulin. The white checkered box represents the Region of Interest (ROI) to be analyzed with arrows pointing to the respective signal intensity values. Scale bar represents 15 μm. D, Bar graph depicting results from acetylated:total tubulin protein analysis of human neurons subjected to various conditions. E, Western blot acetylated-tubulin and βIII-tubulin bands from rat cortical neurons that after 24 hours with or without 10 μM tubacin treatment. F, Key identifying the conditions for each well (for easier identification, empty lanes seen were loaded with sample buffer alone). G, Bar graph depicting results from western blot analysis. Protein levels were normalized to cofilin (Abcam cat. # 42824) load control. Blots were cropped *P < .05; **P < .01; N.S., no significance found transport. We cultured fetal ventral mesencephalic cells (dopamine precursor cells) and allowed them to grow for 7 days before submitting them to the treatment regimen ( Figure 4A ). At DIV 9, cultures were heterogeneous, with 27% AE 2% of control cells staining positive for tyrosine hydroxylase, a dopaminergic marker, and no significant difference across treatments ( Figures 4B and S2A ). Supernatant was collected from cultures that were exposed to DFP with or without CORT pretreatment, and subsequently treated with tubacin at 1 and 10 μM, or with vehicle.
Supernatant was analyzed for dopamine content using high performance liquid chromatography (HPLC) ( Figure 4C ). Exposure to 2 and 20 nM DFP alone resulted in a significant reduction in extracellular dopamine (38% AE 5% and 40% AE 4%, respectively), and this reduction was even greater following CORT pretreatment (46% AE 5% and 55% AE 4%, Figure 4D ). Treatment with 10 μM but not 1 μM tubacin was able to completely restore dopamine release after DFP alone, and partially restore release when cells were exposed to DFP after CORT pretreatment ( Figure 4D ). Tubacin did not significantly alter extracellular dopamine across control cells ( Figure S2B ).
| DISCUSSION
The present studies are the first to use cultured rodent and humanderived neurons to demonstrate that hormonal changes resulting from chemically induced stressors can exacerbate the negative consequences of OP exposure on microtubule and microtubule-related events in the axon. We used both human and rat neurons as a crossvalidation because rat neurons are more amenable to established microtubule-related analyses, while human neurons are a better path toward therapy, given that some features of human neurodegeneration are not reflected in rodents. 32, 33 In the future, an even more refined option would be to use induced pluripotent cell lines from the GW veterans themselves, given that genetic and possibly epigenetic factors potentially relevant to disease susceptibility would be preserved. 34 For now, the results on the human cells confirm that, as with the rat neurons, DFP causes a decrease in tubulin acetylation.
The work on rat neurons indicates that pharmacologic restoration of tubulin acetylation, lowered by DFP AE CORT, rescues various cellular events impaired by DFP AE CORT.
While microtubule acetylation generally correlates with microtubule stability, the correlation depends upon the levels and activity of the enzyme(s) that acetylates tubulin after it becomes incorporated into the microtubule, as well as the enzyme(s) that deacetylates the tubulin after it is released from the microtubule during bouts of disassembly. [35] [36] [37] The live-imaging of microtubule dynamics shows DFP/CORT reduces the number of assembly excursions, which is not easily explained by diminished microtubule stability. Tubacin corrected for the deficit in microtubule dynamics, presumably because various proteins, such as microtubule-severing proteins, interact differently with the microtubule, depending on its acetylation status. 35 The finding that a higher tubacin concentration is needed to correct the acetylation deficit produced by higher DFP concentration suggests that the DFP/CORT may affect the levels or activity of the relevant enzymes. For example, if DFP/CORT increases HDAC6 levels or activity, a higher concentration of tubacin would be needed to inhibit the available enzyme. OPs used at subthreshold levels undoubtedly affect a variety of proteins and pathways, some of which are obviously microtubulerelated and others of which are not as direct or obvious in their relationship to microtubules. In terms of therapy for sufferers of GWI, the question is whether restoring microtubule acetylation to a more normal status will translate into improvements in cognition and sleep, and help alleviate headaches and other symptoms of the disease. Deficits in mitochondria transport could explain some GWI symptoms, such as fatigue, and hence HDAC6 inhibitors might be helpful in treating those symptoms. We are especially encouraged by our dopamine release results, which suggest that a complex process directly related to neurotransmission, and one that could potentially go awry at many different levels, can be corrected by this treatment.
Reports exist in the literature of other neurodegenerative diseases that involve microtubule deacetylation, with symptoms improved in animal models by HDAC6 inhibitors. [38] [39] [40] [41] In that regard, efforts are already underway to develop therapeutics that can be translated to human patients. Our next step is to test the effectiveness of such an approach on an animal model for GWI. From there, translation to human patients using new generations of HDAC6 inhibitors will be our goal.
In conclusion, the results presented here provide new mechanistic clues to the cellular basis of GWI, and point to a therapeutic strategy that may reverse neuronal decline in sufferers.
| MATERIALS AND METHODS

| Cell culture 4.1.1 | Rat cortical neurons
Primary cortical neurons were prepared as previously described. 42 Briefly, the pregnant Sprague-Dawley rat was euthanized on E18 in accordance with Public Health Services Policy on Humane Care and Use of Laboratory Animals, and fetuses were removed. The cortices from both hemispheres of each fetal rat brain were excised, dissociated and plated at a concentration of 500 000 cells per well in 6-well plates (for western blots) or 35 000 cells per well in glassbottomed dishes (for live-cell imaging).
| Rat ventral mesencephalon neurons
The ventral mesencephalon was isolated from fetuses removed from a Sprague-Dawley rat on E14. Cells were isolated and dissociated according to a previously published protocol. 
| Assessing changes in microtubule dynamics
Rat cortical neurons were plated at a density of 35 000 cells per well, allowed to grow for 8 days, and transfected to express GFP-tagged EB3 using Lipofectamine 2000 (ThermoFisher) according to the published product protocol. Cells were imaged using a Zeiss AxioObserver Z1 inverted scope equipped with a 1.46 NA ×100 oil objective and a Zeiss Axiocam 506 mono CCD camera. Images were captured every 1 second for a total of 2.5 minutes at a fixed exposure time across conditions. Movies were analyzed using the MultiKymograph plugin for FIJI (ImageJ).
| Determination of released dopamine after OP exposure
Extracellular dopamine was quantified by electrochemical detection-HPLC (HPLC-ECD). Reagents, chemicals, standard preparation and mobile phase were prepared as previously published. 
| Protein quantification and western blotting
Protein content of each sample was quantified using the Thermo Scientific Pierce BCA Protein Assay Kit (ThermoFisher Scientific; Cat. # 23227). Western blotting was performed using standard methods, developed using the Bio-Rad Chemidoc MP Imaging System, and quantified using the Bio-Rad Image Lab software. Antibody information is provided in figure legends.
| Tubacin treatment
Tubacin (Cayman Chemical; Cat. # 537049-40-4) was used at a concentration of 1 or 10 μM, as established previously. 45 Tubacin was added into culture media immediately after the 24-hour DFP treatment and incubated with cells for 24 hours. Cells were then either lysed for western blotting or imaged to assess mitochondrial transport or microtubule dynamics. Supernatant was collected after 24 hours post tubacin.
| Experimental design and data analysis
Western blots and dopamine experiments were repeated 4 times to ensure reproducibility and power. 
